PMGC HOLDINGS INC. Foreign Currency Transaction Gain (Loss), before Tax
PMGC HOLDINGS INC. (ELAB) reported Foreign Currency Transaction Gain (Loss), before Tax of -$9.03 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Other Income
us-gaap:ForeignCurrencyTransactionGainLossBeforeTax · last filed 2026-08-14
- PMGC HOLDINGS INC. foreign currency transaction gain (loss), before tax for the quarter ending 2026-06-30 was -$9.03K, a 1122.65% decline year-over-year.
- PMGC HOLDINGS INC. foreign currency transaction gain (loss), before tax for the quarter ending 2026-03-31 was -$11.55K.
- PMGC HOLDINGS INC. foreign currency transaction gain (loss), before tax for the quarter ending 2025-12-31 was -$1.56K.
- PMGC HOLDINGS INC. foreign currency transaction gain (loss), before tax for the quarter ending 2025-09-30 was -$4.17K, a 521.19% decline year-over-year.
- PMGC HOLDINGS INC. foreign currency transaction gain (loss), before tax for fiscal 2025 was -$5.24K.
- PMGC HOLDINGS INC. foreign currency transaction gain (loss), before tax for fiscal 2024 was -$5.85K.
- PMGC HOLDINGS INC. foreign currency transaction gain (loss), before tax for fiscal 2023 was -$6.13K.
- PMGC HOLDINGS INC. foreign currency transaction gain (loss), before tax for fiscal 2022 was -$2.75K.
| Period end | Foreign Currency Transaction Gain (Loss), before Tax 3 month | Foreign Currency Transaction Gain (Loss), before Tax 3 month as first filed | Foreign Currency Transaction Gain (Loss), before Tax 6 month | Foreign Currency Transaction Gain (Loss), before Tax 6 month as first filed | Foreign Currency Transaction Gain (Loss), before Tax 9 month | Foreign Currency Transaction Gain (Loss), before Tax 9 month as first filed | Foreign Currency Transaction Gain (Loss), before Tax 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$9.03K 10-Q · filed 2026-08-14 | -$20.58K 10-Q · filed 2026-08-14 | -$22.14K derived: sum of 3 quarters · filed 2026-08-14 | -$26.32K derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2026-03-31 | -$11.55K 10-Q · filed 2026-05-15 | -$13.11K derived: sum of 2 quarters · filed 2026-05-15 | -$17.29K derived: sum of 3 quarters · filed 2026-05-15 | -$16.40K derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2025-12-31 | -$1.56K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | -$5.74K derived: sum of 2 quarters · filed 2026-03-30 | -$4.85K derived: sum of 3 quarters · filed 2026-08-14 | -$5.24K 10-K · filed 2026-03-30 | |||
| 2025-09-30 | -$4.17K 10-Q · filed 2025-11-14 | -$3.29K derived: sum of 2 quarters · filed 2026-08-14 | -$3.68K 10-Q · filed 2025-11-14 | -$8.53K derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2025-06-30 | $883.00 10-Q · filed 2026-08-14 | $497.00 10-Q · filed 2026-08-14 | -$4.36K derived: sum of 3 quarters · filed 2026-08-14 | -$3.37K derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2025-03-31 | -$386.00 10-Q · filed 2026-05-15 | -$5.24K derived: sum of 2 quarters · filed 2026-05-15 | -$4.25K derived: sum of 3 quarters · filed 2026-05-15 | -$4.44K derived: sum of 4 quarters · filed 2026-05-15 | |||
| 2024-12-31 | -$4.86K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | -$3.87K derived: sum of 2 quarters · filed 2026-03-30 | -$4.05K derived: sum of 3 quarters · filed 2026-03-30 | -$5.85K 10-K · filed 2026-03-30 | |||
| 2024-09-30 | $991.00 10-Q · filed 2025-11-14 | -$875.00 10-Q · filed 2024-11-14 | $803.00 derived: sum of 2 quarters · filed 2025-11-14 | -$990.00 10-Q · filed 2025-11-14 | -$1.66K 10-Q · filed 2024-11-14 | -$7.60K derived: sum of 4 quarters · filed 2025-11-14 | |
| 2024-06-30 | -$188.00 10-Q · filed 2025-08-13 | -$244.00 10-Q · filed 2024-08-14 | -$1.98K 10-Q · filed 2025-08-13 | -$785.00 10-Q · filed 2024-08-14 | -$8.59K derived: sum of 3 quarters · filed 2025-08-13 | -$5.48K derived: sum of 4 quarters · filed 2025-08-13 | |
| 2024-03-31 | -$1.79K 10-Q · filed 2025-05-14 | -$541.00 10-Q · filed 2024-05-15 | -$8.40K derived: sum of 2 quarters · filed 2025-05-14 | -$5.29K derived: sum of 3 quarters · filed 2025-05-14 | -$7.66K derived: sum of 4 quarters · filed 2025-05-14 | ||
| 2023-12-31 | -$6.61K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | -$3.50K derived: sum of 2 quarters · filed 2025-03-28 | -$5.87K derived: sum of 3 quarters · filed 2025-03-28 | -$6.13K 10-K · filed 2025-03-28 | |||
| 2023-09-30 | $3.11K 10-Q · filed 2024-11-14 | $3.11M 10-Q · filed 2023-12-11 | $739.00 derived: sum of 2 quarters · filed 2024-11-14 | $480.00 10-Q · filed 2024-11-14 | $480.00K 10-Q · filed 2023-12-11 | $1.39M derived: sum of 4 quarters · filed 2024-11-14 | |
| 2023-06-30 | -$2.37K 10-Q · filed 2024-08-14 | -$2.63K 10-Q · filed 2024-08-14 | $1.39M derived: sum of 3 quarters · filed 2024-08-14 | $1.85M derived: sum of 4 quarters · filed 2024-08-14 | |||
| 2023-03-31 | -$259.00 10-Q · filed 2024-05-15 | $1.39M derived: sum of 2 quarters · filed 2024-05-15 | $1.85M derived: sum of 3 quarters · filed 2024-05-15 | ||||
| 2022-12-31 | $1.39M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | $1.85M derived: sum of 2 quarters · filed 2024-03-29 | -$2.75K 10-K · filed 2024-03-29 | ||||
| 2022-09-30 | $465.00K 10-Q · filed 2023-12-11 | -$1.39M 10-Q · filed 2023-12-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B |